| Revenue Growth | H1 revenue $10.9M (+6%); Medical $7.1M (+289%); Industrial (+156%); Alt-Energy declined. |
|---|---|
| Mgmt Confidence | High confidence in FY2028 visibility due to record $7.2M and $3.6M orders. |
| Demand Visibility | Strong; $10.79M in recent major program wins mostly shipping in FY2028. |
| Order Book | Backlog $9.5M at Aug 31 (+23% QoQ); subsequent $7.19M energy order. |
| Margin Trends | Gross margin expanded to 55% from 51% due to favorable product mix. |
| Op. Leverage | Operating income grew 41% on 6% revenue growth; significant leverage expected 2028. |
| Pricing Power | Higher ASPs achieved via systems integration and forward-deployed engineering value-add. |
| Vol vs Price | Growth driven by higher ASP production systems versus lower-cost R&D units. |
| Segment Growth | Medical and Industrial segments outperformed; Alternative Energy seeing long-term recovery. |
| New Clients | Expanded existing energy customer with record $7.2M order for 10 systems. |
| Capex & Debt | Zero debt; $17.7M cash; $700k initial mezzanine expansion capex planned December. |
| Commentary | Shift from selling components to integrated production solutions via Forward Deployed Engineering. |
| New Launches | Expanding into drug-eluting balloons and defense-sector optics applications. |
Growth
H1 revenue rose 6% to $10.9M; medical sales surged 289% to $7.1M.
Outlook
Backlog reached $9.5M plus $10.8M in new orders, providing high visibility into FY2028.
Risks
Management used vague language regarding specific Q3/Q4 margins, citing variability and 'unusually favorable' recent mix.
The company's earnings call, NASDAQ: SOTK, and its 8-K filed with the SEC. Summary written with AI assistance from the call.
Earnings call webcast ↗ Watch on YouTube ↗
Sono Tek Corp: key numbers
- Share price
- $4.14Close, Nov 16
- Market cap
- $65.1M
- Shares outstanding
- 15.75MLatest SEC cover page
- Sector
- Technology
- Industry
- Special Industry Machinery, NECSIC 3559
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Sono Tek Corp
All →Sono Tek Q2 2026 Results: Net Income $366K, Down 13.5% YoY
Sono-Tek Corporation reported a 6% increase in net sales to $10.89 million for the six months ended August 31, 2026, compared to the prior year. Net income grew to $1.11 million, driven by improved gross margins and higher interest income, despite an increase in operating expenses and a net unrealized loss on marketable securities.
- Key figure
- Net income $366K · -13.5% YoY
Sono Tek Financial Results
Sono-Tek reported fiscal second quarter 2027 results with net sales of $5.23 million and net income of $366,000. For the first half of the fiscal year, revenue increased 6% to $10.89 million, driven by a 289% surge in medical market sales. The company reiterated its full-year guidance for flat to modest revenue growth due to the timing of large orders.
- Term
- Q2 2027
“Fiscal 2027 is progressing well, with solid first-half revenue growth, meaningful gross margin expansion and strong improvement in operating profitability. These results reflect disciplined execution across our operations and continued progress with our strategy of focusing on higher-value production systems in advanced technology markets, particularly medical devices.”
Steve Harshbarger, President and Chief Executive Officer